Après votre arrêt cardiaque, vous prendrez bien un peu d'élixir de (sur)vie [After your heart arrest, would you like to test a medicinal elixir?].
Data(s) |
2005
|
---|---|
Resumo |
So far, cardiac arrest is still associated with high mortality or severe neurological disability in survivors. At the tissue level, cardiac arrest results into an acute condition of generalized hypoxia. A better understanding of the pathophysiology of ischemia-reperfusion and of the inflammatory response that develops after cardiac arrest could help to design novel therapeutic strategies in the future. It seems unlikely that a single drug, acting as a <magic bullet>, might be able to improve survival or neurological prognosis. Lessons learned from pathophysiological mechanisms rather indicate that combined therapies, involving thrombolysis, neuroprotective agents, antioxidants and anti-inflammatory molecules, together with temperature cooling, might represent helpful strategies to improve patient's outcome after cardiac arrest. |
Identificador |
http://serval.unil.ch/?id=serval:BIB_74D0B2079E58 isbn:1660-9379 (Print) pmid:15786650 |
Idioma(s) |
fr |
Fonte |
Revue Médicale Suisse, vol. 1, no. 6, pp. 448-451 |
Palavras-Chave | #Anti-Inflammatory Agents/therapeutic use; Antioxidants/therapeutic use; Fibrinolytic Agents/therapeutic use; Heart Arrest/prevention & control; Humans; Neuroprotective Agents/therapeutic use |
Tipo |
info:eu-repo/semantics/article article |